Advertisement
Document › Details
LifeSci Advisors, LLC. (6/21/21). "Press Release: LifeSci Advisors Nordic Biotech Summit".
Region | Scandinavia | |
Organisation | LifeSci Advisors LLC | |
Group | LifeSci (Group) | |
Organisation 2 | Hadean Ventures AS | |
Product | LifeSci Advisors Nordic BioTech Summit 2021 DIGITAL | |
Product 2 | BIOTECH | |
Person | Akay, Ingrid Teigland (Hadean Ventures 201604 Managing Director) | |
Person 2 | Aguiar-Lucander, Renée (Pharmalink AB 201708 CEO) | |
The Nordic life science industry has expanded rapidly over the last 20 years, with hundreds of innovative biotech companies emerging from large pharmaceutical companies or academic and private research. LifeSci Advisors is looking forward to hosting a selection of these dynamic biotechs at this year’s LifeSci Advisors Nordic Biotech Summit, that will take place as a fully digital live-event on 29 June, 2021.
A selection of exciting companies have registered to present to international institutional investors and sector analysts. Presenting companies range from USD 100M in market cap, right up to some of the best known in the region with USD 1.3bn+ market cap, such as Y-mAbs Therapeutics and Zealand Pharma.
The conference agenda will be supplemented by live panel discussions, including “Overcoming the Challenges of a Dual Listing” and “Diversifying a Shareholder Base Beyond Home Markets”. Speakers include Anthony Leach, Head of Sector Healthcare at Pareto Securities; Ingrid Teigland Akay, Managing Partner at Hadean Ventures; Renee Aguiar-Lucander, CEO at Calliditas; Adam Kostyál, Senior Vice President of Listing Services, Europe at NASDAQ ; Hans T. Schambye, CEO at Galecto; Matt Dallas, CFO at Zealand Pharma; Nathan Aijashvili, Partner at Latham & Watkins and Nick Moore, Managing Director Healthcare Investment Banking at Stifel Financial Corp.
Media representatives are welcome to register and attend the event. For more information on the agenda, full list of presenting companies and registration, please visit the LifeSci Advisors Nordic BioTech Summit website or contact
Abigail Healy
+44 769-272-611
Business Development
ahealy@lifesciadvisors.com
Karen Davis
Managing Director
+ 1 646-876-3764
kdavis@lifesciadvisors.com
Frank Schwarz
Media Relations
+ 49 17 26 15 31 60
fschwarz@lifesciadvisors.com
Record changed: 2023-06-05 |
Advertisement
More documents for LifeSci (Group)
- [1] Cellectis S.A.. (12/29/22). "Press Release: Mayflower Bioventures Launches Its First Spin-Out, Primera Therapeutics, in Strategic Collaboration with Cellectis to Develop a Gene Editing Platform to Treat Mitochondrial Diseases". New York, NY....
- [2] Polyphor Ltd.. (6/28/21). "Press Release: Polyphor Provides Update on the Phase III FORTRESS Study of Balixafortide in Patients with Advanced HER2 Negative Breast cancer". Allschwil....
- [3] Evaxion Biotech A/S. (4/20/21). "Press Release: Evaxion Biotech Presents Paper on Potential of Deep Data on Immune Complex Stability to Optimize Cancer Immunotherapy". Copenhagen....
- [4] Evaxion Biotech A/S. (4/6/21). "Press Release: Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business Update". Copenhagen....
- [5] Medigene AG. (1/13/21). "Press Release: Medigene Expands Patent Protection of Its Technologies in Key Markets, the USA and Europe". Planegg-Martinsried....
- [6] Erytech Pharma. (1/4/21). "Press Release: Erytech to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event". Lyon & Cambridge, MA....
- [7] Amolyt Pharma SAS. (6/2/20). "Press Release: Alizé Pharma 3 Announces Rebranding to Amolyt Pharma, Reflecting a Strategic Focus on Building and Advancing a Portfolio of Therapeutic Peptides for Rare Endocrine and Metabolic Diseases". Lyon & Newton, MA....
- [8] Sensorion S.A.. (12/2/19). "Press Release: Sensorion Announces Results From SENS-111 Phase 2b Trial in Acute Unilateral Vestibulopathy". Montpellier....
- [9] BioLineRx Ltd.. (8/6/19). "Press Release: BioLineRx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". Tel Aviv....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top